NDC 73377-067-01 - Lanthanum Carbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-067
- Requested NDC
- 73377-067-01
- Package NDCs from labels
- 73377-067-01, 73377-067-02, 73377-067-03, 73377-067-04, 73377-067-05
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-07-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lanthanum Carbonate - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-07-13 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-067-01 | Lanthanum Carbonate | 500 g in 1 JAR | POWDER | 500 | 4 | |
| 73377-067-02 | Lanthanum Carbonate | 5000 g in 1 JAR | POWDER | 5000 | 4 | |
| 73377-067-03 | Lanthanum Carbonate | 2000 g in 1 JAR | POWDER | 2000 | 4 | |
| 73377-067-04 | Lanthanum Carbonate | 1000 g in 1 JAR | POWDER | 1000 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lanthanum carbonate | LANTHANUM CARBONATE | Prasco Laboratories | bb263fe8-2bdf-4dba-807f-194f54a73654 | 2025-12-15 | Warnings, Adverse reactions | 490D9F069T |
| Lanthanum Carbonate | LANTHANUM CARBONATE | Ascend Laboratories, LLC | 22b07167-2b7b-42ba-9ae9-cf58c98a2ab2 | 2025-05-06 | Warnings, Adverse reactions | 490D9F069T |
| Lanthanum carbonate | LANTHANUM CARBONATE | Teva Pharmaceuticals USA, Inc. | e4b88992-ecb0-455b-b68c-5c4e6d3cf521 | 2025-01-30 | Warnings, Adverse reactions | 490D9F069T |
| Fosrenol | LANTHANUM CARBONATE | Takeda Pharmaceuticals America, Inc. | f10776b2-2c25-4343-aabe-68f302e5cb54 | 2024-12-31 | Warnings, Adverse reactions | 490D9F069T |
| Lanthanum Carbonate | LANTHANUM CARBONATE | Lupin Pharmaceuticals, Inc. | 91556a42-5e16-4f86-bae9-a8cdd6b182a6 | 2024-11-07 | Warnings, Adverse reactions | 490D9F069T |
| Lanthanum carbonate | LANTHANUM CARBONATE | Cipla USA Inc. | 1d5ff930-1189-4e96-bdfb-9fd9c2c83d1b | 2024-08-01 | Warnings, Adverse reactions | 490D9F069T |
| Lanthanum carbonate | LANTHANUM CARBONATE | Exelan Pharmaceuticals, Inc. | 16b0e6f5-4fc9-448c-994a-cb9dd8b03654 | 2024-08-01 | Warnings, Adverse reactions | 490D9F069T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.